A detailed history of Gibbs Wealth Management transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Gibbs Wealth Management holds 393 shares of MEDP stock, worth $231,905. This represents 0.06% of its overall portfolio holdings.

Number of Shares
393
Previous 561 29.95%
Holding current value
$231,905
Previous $288 Million 18.93%
% of portfolio
0.06%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 23, 2026

SELL
$501.22 - $605.2 $84,204 - $101,673
-168 Reduced 29.95%
393 $234 Million
Q3 2025

Oct 30, 2025

SELL
$308.88 - $514.16 $53,436 - $88,949
-173 Reduced 23.57%
561 $288 Million
Q2 2025

Aug 13, 2025

BUY
$277.23 - $315.28 $203,486 - $231,415
734 New
734 $230 Million
Q2 2024

Nov 04, 2025

SELL
$372.0 - $424.34 $310,620 - $354,323
-835 Closed
0 $0
Q1 2024

Nov 04, 2025

BUY
$284.87 - $413.31 $78,054 - $113,246
274 Added 48.84%
835 $337 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $18.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Gibbs Wealth Management Portfolio

Follow Gibbs Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gibbs Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Gibbs Wealth Management with notifications on news.